- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05050370
A Brief SMART Exercise Instant Messaging Support Intervention - a Pilot Study
A Brief SMART Exercise With Chat-based Instant Messaging Personalised Support Intervention
Study Overview
Status
Intervention / Treatment
Detailed Description
Lung cancer is one of the most common cancer, globally and locally. Patients with lung cancer are in a uniquely challenging situation in their disease, comorbidities, and treatment that may lead to worsened symptoms and many negative health consequences, including fatigue, irritability, and impaired daytime functioning. Physical activity (PA) is defined as 'any bodily movement produced by skeletal muscle that results in energy expenditure'. Several health benefits of increased PA have been reported for people with cancer. PA plays a critical role across the cancer trajectory, from prevention through to postdiagnosis and has been proposed as an alternative for improving physical and psychosocial health outcomes, reducing cancer recurrence, and cancer-specific and all-cause mortality. Although there are a variety of exercise intervention programs for cancer patients, those programs were quite intensive, requiring individuals to commit extra time and effort. Most clinicians underutilise exercise therapy, regardless of its low-cost way to improve symptoms and potential health outcomes. Feeling of overwhelmed appointments, lack of time, other barriers, including high cost and limited access to facilities are the most frequently reported barriers that prevent people from starting and maintaining exercise. Low motivation, fear to exercise, lack of knowledge about benefits are the most common barriers of engaging in physical activity for cancer patients.
Hence, the current proposal is to use a brief messaging lifestyle modification intervention program to incorporating simple and easy-to-do patient-centred home-based lifestyle-integrated exercise (light to moderate physical activity) into daily activities of patients with lung cancer.
The aims are to explore the feasibility of using instant messaging to enhance physical activity and improve their fatigue, emotion and quality of life, and obtain feedback from patients for intervention and study design improvement.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Agnes Lai, PhD
- Phone Number: 852-3917-6328
- Email: agneslai@hku.hk
Study Contact Backup
- Name: Asa Choi, MA
- Phone Number: 852-3917-6563
- Email: asachoi@hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Queen Mary Hospital
-
Principal Investigator:
- Agnes YK Lai, PhD
-
Contact:
- Agnes Lai, PhD
- Phone Number: 3917-6283
- Email: agneslai@hku.hk
-
Contact:
- David Lam, PhD
- Phone Number: 2255-4455
- Email: slnga@hku.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Aged 18 years and above;
- Diagnosis of non-small cell lung cancer or small cell lung cancer
- Fatigue symptom score ≥4 out of 10
- Self-reported engagement of <150 minutes of moderate-intensity PA each week
- Ambulatory and capable of all self-care activities
- Either undergoing or finished oncology therapy and/or support care
- Mentally, cognitively and physically fit to join the trial
- Able to speak and read Chinese;
- Willing to complete the patient-reported outcome questionnaire
- Completion of the Physical Activity Readiness Questionnaire
- Possession of a smartphone with instant messaging functions such as WhatsApp or WeChat.
Exclusion criteria
- Those preparing for lung operation
- Skeletal fragility
- Serious active infection
- Inability to walk
- Severe respiratory insufficiency
- Uncontrolled pain
- Diagnosed psychiatric illness such as major depressive disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lifestyle-integrated exercise and care support
The experimental group will receive a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise and cancer-related information with personalized support.
|
Patients will receive (i) a face-to-face group session and a package of instant messages related to lifestyle-integrated exercise (including breathing, balance, aerobic, strength, stretching exercises), cancer-related care information and support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in fatigue level at 6 week
Time Frame: Baseline and 6 weeks
|
measured by Functional Assessment of Cancer Therapy - Fatigue subscale, the higher scores, the more fatigue.
|
Baseline and 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Anxiety and depressive symptoms at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Hospital Anxiety and Depression Scale, Each item is answered on a 4-point scale (0-3).
The scores for the seven questions on depression are added together to obtain a score ranged from 0 to 21.
The higher score the more depressed.
The scores for the seven questions on anxiety are added together to obtain a score ranged from 0 to 21.
The higher score the more anxiety and depression symptoms.
|
Baseline and 6 weeks
|
Change in sleep quality at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by the Pittsburgh sleep quality index .
The higher the score, the worse the quality.
|
Baseline and 6 weeks
|
Change in Health-related quality of life at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by the European Organization for Research and Treatment of Cancer and Lung Module.
The higher scores the worse the quality.
|
Baseline and 6 weeks
|
Change in Subjective Happiness at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by Subjective Happiness Scale.
The higher scores the more happy.
|
Baseline and 6 weeks
|
Change in Pain at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by a question with a scale from 0 to 10; a score of "0" indicates no pain at all, a score of "10" indicates severe pain.
The higher score, the more pain.
|
Baseline and 6 weeks
|
Change in dyspnea at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by a question with a scale from 0 to 10; a score of "0" indicates no dyspnea at all, a score of "10" indicates severe dyspnea.
The higher score, the more dyspnea.
|
Baseline and 6 weeks
|
Change in activity level at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by pedometer
|
Baseline and 6 weeks
|
Change in hand grip strength at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by a dynamometer
|
Baseline and 6 weeks
|
Change in balance at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by single leg stand test
|
Baseline and 6 weeks
|
Change in flexibility at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by chair sit and reach test
|
Baseline and 6 weeks
|
Change in sleep quality with objective measurement at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by activity monitor on duration of sleep and awake intervals
|
Baseline and 6 weeks
|
Change in physical activity level with objective measurement at 6 weeks
Time Frame: Baseline and 6 weeks
|
measured by accelerometer on the daily walking steps
|
Baseline and 6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Agnes Lai, PhD, The University of Hong Kong
Publications and helpful links
General Publications
- Gopalakrishnan S, Takemoto L. Binding of actin to lens alpha crystallins. Curr Eye Res. 1992 Sep;11(9):929-33. doi: 10.3109/02713689209033490.
- Peddle-McIntyre CJ, Singh F, Thomas R, Newton RU, Galvao DA, Cavalheri V. Exercise training for advanced lung cancer. Cochrane Database Syst Rev. 2019 Feb 11;2(2):CD012685. doi: 10.1002/14651858.CD012685.pub2.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UW20-019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Brief messaging and personalized support
-
Taipei Medical UniversityCompleted
-
VA Office of Research and DevelopmentCompleted
-
Northwestern UniversityRecruitingDepression | Anxiety | Suicidal IdeationUnited States
-
Emory UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Georgia... and other collaboratorsRecruiting
-
Hunter College of City University of New YorkRecruitingAlcohol ConsumptionUnited States
-
The University of Hong KongCompleted
-
University of AlbertaAlberta Health servicesCompletedDepression | Schizophrenia | Bipolar DisorderCanada
-
The University of Hong KongHong Kong Council on Smoking and HealthUnknownSmoking CessationHong Kong
-
University Hospital, LilleNational Cancer Institute, France; Centre Oscar Lambret; University of Lille...TerminatedTumor | Oncologic DisordersFrance
-
University of California, DavisEnrolling by invitationType 1 DiabetesUnited States